Atlas Trials

Study of M7824 and Paclitaxel Combination as a Second-line Treatment in Patients With Recurrent/Metastatic Gastric Cancer

Clinical trial NCT04835896 · COMPLETED

Trial details

NCT number
NCT04835896
Sponsor
Yonsei University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Recurrent/Metastatic Gastric Cancer
Start date
2021-06-02
Primary completion
2023-10-27
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.